Genes involved in hepatocellular carcinoma: Deregulation in cell cycling and apoptosis

Virchows Archiv

Volumn 440, Issue 4, 2002, Pages 345-352

  Tannapfel, Andrea ^a   Wittekind, Christian ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Catenin; Cyclin; Genetic alterations; Hepatocellular carcinoma; p14; p16; p53; Rb

Indexed keywords

AXIN; CANCER GROWTH FACTOR; CARCINOGEN; CATENIN; COMPLEMENTARY DNA; MYCOTOXIN; PROTEIN P53; UVOMORULIN; WNT PROTEIN;

APOPTOSIS; CARCINOGENESIS; CELL ADHESION; CELL CYCLE; CHROMOSOME ABERRATION; DISEASE ASSOCIATION; DNA MICROARRAY; GENE CLUSTER; GEOGRAPHIC DISTRIBUTION; HEMOCHROMATOSIS; HUMAN; LIVER CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MUTATION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VIRUS HEPATITIS;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MUTATION; PRECANCEROUS CONDITIONS;

EID: 0036216526     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-002-0617-x     Document Type: Review

References (66)

1. Absence of p53 gene mutations in hepatocarcinomas from a Mediterranean area of Spain. A study of 129 archival tumour samples
2. Hepatocellular carcinoma associated with focal nodular hyperplasia. Report of a case with clonal analysis
3. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas
4. Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice
5. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity
6. Abnormal nucleotide repeat sequence in the TGF-betaRII gene in hepatocellular carcinoma and in uninvolved liver tissue
7. Identification of human cancer-related genes by naturally occurring Hepatitis B Virus DNA tagging
8. Expression profiling and identification of novel genes in hepatocellular carcinomas
9. The hallmarks of cancer
10. Hypermethylation of tumor suppressor genes in cancer
11. Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas
12. Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas
13. RB tumor suppressor gene expression in hepatocellular carcinoma from patients infected with the hepatitis B virus
14. Mutational hotspot in the p53 gene in human hepatocellular carcinomas
15. The formation of capsule and septum in human hepatocellular carcinoma
16. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors
17. Hepatocellular expression of a dominant-negative mutant TGF-beta type II receptor accelerates chemically induced hepatocarcinogenesis
18. PTEN/MMAC1 mutations in hepatocellular carcinomas: Somatic inactivation of both alleles in tumors
19. Mutation analysis of transforming growth factor beta type II receptor, Smad2, and Smad4 in hepatocellular carcinoma
20. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas
21. Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: Their relationship to clinicopathological features
22. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis
23. High frequency of p16INK4A gene alterations in hepatocellular carcinoma
24. Microsatellite instability and loss of heterozygosity at DNA mismatch repair gene loci occurs during hepatic carcinogenesis
25. p16 (INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma
26. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC
27. Mortality by cause for eight regions of the world: Global burden of disease study
28. Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level
29. p53 gene mutation spectrum in hepatocellular carcinoma
30. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: Identification of genes involved in viral carcinogenesis and tumor progression
31. p53 mutation in hepatocellular carcinoma after aflatoxin exposure
32. Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma
33. The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma
34. Association of the APC gene product with β-catenin
35. Chromosomal aberrations in human hepatocellular carcinomas associated with hepatitis C virus infection detected by comparative genomic hybridization
36. Microsatellite instability in European hepatocellular carcinoma
37. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
38. Acquired expression of transcriptionally active p73 in hepatocellular carcinoma cells
39. Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays
40. Deletion of the E-cadherin gene in hepatitis B virus-positive Chinese hepatocellular carcinomas
41. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
42. Biallelic inactivation of the APC gene is associated with hepatocellular carcinoma in familial adenomatous polyposis coli
43. Human hepatic preneoplasia: Phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia
44. Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma
45. Apoptosis and proliferation in relation to histopathological variables and prognosis in hepatocellular carcinoma
46. Decreased expression of p27 protein is associated with advanced tumor stage in hepatocellular carcinoma
47. Frequency of p16 (INK4A) alterations and K-ras mutations in intrahepatic cholangio-carcinoma of the liver
48. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas
49. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells
50. Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation
51. Genetic heterogeneity of hepatocellular carcinoma
52. p53 mutations in British patients with hepatocellular carcinoma: Clustering in genetic hemochromatosis
53. Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene
54. Failure to detect genetic alteration of the mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) gene in hepatocellular carcinomas in Japan
55. p53 mutation pattern in hepatocellular carcinoma in workers exposed to vinyl chloride
56. Frequent k-ras-2 mutations and p16 (INK4A) methylation in hepatocellular carcinomas in workers exposed to vinyl chloride
57. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: Relationship to disease stage, tumor size, and cirrhosis
58. Beta-catenin mutation and overexpression in hepatocellular carcinoma: Clinicopathologic and prognostic significance
59. Distinctive gene expression profiles associated with Hepatitis B virus x protein
60. Smad2 and Smad4 gene mutations in hepatocellular carcinoma
61. Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma
62. Hepatic hyperplasia in noncirrhotic fatty livers: Is obesity-related hepatic steatosis a premalignant condition?
63. PTEN/MMAC1 mutations in hepatocellular carcinomas
64. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity
65. A novel growth suppressor gene on chromosome 17p13.3 with a high frequency of mutation in human hepatocellular carcinoma